Global DM1 Commercialization Leader

BioSpace; Waltham (MA); On-site; USD 272,000 - 340,000; Full time

Job summary

Dyne Therapeutics is seeking a VP, DM1 Commercial Asset Lead to drive global commercialization strategy and create value for the DM1 portfolio. You will lead market analysis, competitive positioning and lifecycle input to maximize patient reach and payer access.

As a Program Team member, you will oversee launch readiness across markets, collaborate with affiliate teams and cross‑functional partners, and guide strategic imperatives from the U.S. onward. Role is onsite in Waltham, MA.

Qualifications

• Bachelor’s degree in a relevant scientific, medical, or business discipline required; advanced degree strongly preferred
• Minimum of 20 years of experience in the biopharmaceutical industry
• 15+ years of commercialization and cross‑functional leadership experience
• Extensive experience leading global product launches, including a minimum of 3 launches
• Rare disease experience strongly preferred; neuromuscular experience highly advantageous
• Proven ability to influence global and U.S. market access and reimbursement readiness
• Demonstrated success developing global commercialization strategies
• Experience collaborating across clinical, medical, regulatory, supply, and commercial functions
• Ability to synthesize complex data to guide strategy

Responsibilities

• Define global asset commercialization strategy and plan to achieve milestones and timelines for successful launches
• Lead global launch planning and readiness across key markets, starting with the U.S.
• Serve as a key member of the Program Team and lead the DM1 Commercial Sub‑Team
• Build a credible external presence with KOLs, patient groups, and payers; support board discussions

Skills

Global product launches

Cross-functional leadership

Strategic market analysis

Stakeholder engagement

Executive communication

Payer & access strategy

Education

Bachelor’s degree in a relevant scientific/medical/business discipline

Advanced degree strongly preferred

20+ years in biopharmaceutical industry

15+ years commercialization leadership

Rare disease / neuromuscular experience advantageous

Proven track record delivering business objectives

Job description

Dyne Therapeutics is seeking a VP, DM1 Commercial Asset Lead to drive global commercialization strategy and create value for the DM1 portfolio. You will lead market analysis, competitive positioning and lifecycle input to maximize patient reach and payer access.

As a Program Team member, you will oversee launch readiness across markets, collaborate with affiliate teams and cross‑functional partners, and guide strategic imperatives from the U.S. onward. Role is onsite in Waltham, MA.